Paul M Harari

Trials

Studies that name Paul M Harari as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:54 UTC. Open this list on ClinicalTrials.gov

• Ph2/Ph3
  NCT05050162 · Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

  NRG Oncology · active not recruiting · Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma · principal investigator
• N/A
  NCT03286972 · PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning

  University of Wisconsin, Madison · terminated · Head and Neck Neoplasms · principal investigator
• Ph2/Ph3
  NCT01810913 · Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

  National Cancer Institute (NCI) · suspended · Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7, Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 · principal investigator
• N/A
  NCT00415025 · Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

  University of Wisconsin, Madison · completed · Head and Neck Cancer, Long-term Effects Secondary to Cancer Therapy in Adults, Oral Complications of Radiation Therapy · study chair
• Ph2
  NCT00084318 · Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck

  Radiation Therapy Oncology Group · completed · Head and Neck Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Head and Neck Cancer SPORE at the University of Wisconsin
  P50CA278595 · NCI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2022 to 2026 · $2,142,468 awarded in 2026
  Same name and institution; not confirmed by an ID
• Head and Neck Cancer SPORE at the University of Wisconsin
  P50DE026787 · NIDCR · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2016 to 2020 · $2,160,041 awarded in 2020
  Same name and institution; not confirmed by an ID
• EGFR/Radiation Response and Resistance Interactions
  R01CA113448 · NCI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2006 to 2010 · $253,359 awarded in 2010
  Same name and institution; not confirmed by an ID
• SURGERY FOLLOWED BY CHEMORADIOTHERAPY + C225 FOR HEAD AND NECK CARCINOMA
  M01RR003186 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2006 to 2007 · $772 awarded in 2007
  Same name and institution; not confirmed by an ID
• POLYAMINE MODULATION OF SQUAMOUS CANCER GROWTH KINETICS
  R29CA066786 · NCI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 1995 to 1999 · $105,555 awarded in 1999
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• NRG Oncology Network Group Operations Center
  U10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL, NORMAN WOLMARK · fiscal years 2015 to 2026
  Named on NCT05050162, NCT01810913
• U10CA021661
  RePORTER returned no project for this number; it is shown as the registry gives it.
  Named on NCT01810913
• UW Comprehensive Cancer Center Support
  P30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · fiscal years 2014 to 2026
  Named on NCT00415025